Remdesivir investigational trials in COVID-19: a critical reappraisal. REVISED v2
A lot of effort are generally made by the industry during outbreak to promote clinical trials with new drugs. Here we review evidence of the 10 most recent reports on remdesivir. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention.
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14251
- Acceso en línea:
- https://doi.org/10.1016/j.nmni.2020.100745
http://hdl.handle.net/20.500.12010/14251
- Palabra clave:
- Investigational trials
COVID-19
Critical reappraisal
REVISED v2
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)